Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Trans and Non-binary Prostate-Specific Antigen Reference Interval Determination Study

NCT06987045 is registered in ClinicalTrials.gov with Queen Mary University of London as lead sponsor.

NCT NCT06987045
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06987045 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Trans and Non-binary Prostate-Specific Antigen Reference Interval Determination Study
Lead sponsor
Queen Mary University of London
Phase
Observational
Overall status
Recruiting
Start date
April 4, 2026
Completion date
March 31, 2028
Enrollment
500 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

prostate ca